Dr Spero R Cataland (The Ohio State University, Wexner Medical Centre, Columbus, OH, USA) joins us for Rare Disease Day to discuss the importance of rapid diagnosis of acquired thrombotic thrombocytopenic purpura (aTTP), a rare blood disorder in which blood clots form in small blood vessels throughout the body. In this interview, Dr Cataland discusses the risks associated with aTTP, the long-term complications and the impact of living with this disease day to day.
Touch Medical Media is supporting Rare Disease Day (28 February 2022) to shine a light on healthcare inequalities for people living with Rare Diseases, focusing on patient quality of life and the difficulty of diagnosing patients early.
Questions:
- Could you tell us about acquired/immune TTP and how it impacts patients’ daily lives? (0:35)
- Why is a rapid diagnosis of aTTP important for patients and what are the challenges in achieving this? (4:40)
- What are the current management options for patients with aTTP and what more is needed to prevent long-term complications and prevent relapse? (7:10)
Disclosures: Spero Cataland is a consultant to Sanofi and Takeda.
Support: The production of this video was supported by Touch Medical Media.
Other content available in support of Rare Disease Day includes:
- Damara Ortiz: The impact of Pompe disease and the importance of newborn screening
- Shekita Green: Living with neuromyelitis optica spectrum disorder (NMOSD) – A patient perspective
- Megan Hunter: Living with myasthenia gravis – A journey to diagnosis
- Ethan Crough: Living with achondroplasia – Celebrating diversity and increasing awareness
- Said Beydoun: Understanding myasthenia gravis and the impact on patients’ quality of life
- Jackie Palace: Improving diagnosis and treatment of neuromyelitis optica spectrum disorder
- Richard Keen, Rare Disease Day 2022: Rare bone diseases – Diagnosis, management and patient quality of life
